PharmaTwoB was founded by a group of highly experienced professionals from the Israeli pharmaceutical industry, with strong track record in drug delivery, chemistry, finance and strategic planning. The company’s management and staff are highly skilled scientists with many years of experience in research and development of drugs, pharmaceutical development and clinical trials.
Dr. Nurit Livnah, CEO
Dr. Livnah received her Ph.D in Chemistry from the Weizmann Institute of Science. She brings over 18 years of experience in drug discovery and development, project management and team leadership. Among her former positions, she spent 8 years at Peptor Ltd, where she led projects in anti-cancer drug development, first as the Head of Chemistry group and later as VP R&D. She then served as Director of research of DeveloGen Israel, and then as VP R&D at Proteologics Ltd, where she was involved in drug discovery and development of anti-cancer and anti-viral agents. She joined Pharma Two B upon the establishment of the company in January 2008.
Irit Zalayet, CFO
Ms. Irit Zalayet CPA serves as Pharma Two B’s CFO as of September 2010. Prior to this Ms. Zalayet served as deputy CEO of Kesselman & Kesselman Trust Co. (1971) Ltd. and as a CPA at PwC Israel. Irit completed her Bachelors in Economics and Accounting and her M.A. in Law; both degrees are from The Bar- Ilan University. Ms. Zalayet also serves as the CFO of a related group party Stem Cell Medicine.
Hadas Friedman, VP QA, RA & Clinical Affairs
Ms. Friedman serves as Pharma Two B’s VP QA, RA and Clinical Affairs since 2013. Prior to this Ms. Friedman served as the VP QA, RA and Clinical Affairs at Intec Pharma from 2004. Previous companies include Procognia and Rafa Laboratories. Hadas has completed a Bachelors of Science and a Masters of Science at the Bar-Ilan University.